News

During its 43rd Annual Meeting in Denver, the International Society of Heart and Lung Transplantation will honor the recipient of the ISHLT’s 2023 Lifetime Achievement Award, Jon Kobashigawa, MD.

During its 43rd Annual Meeting in Denver, the International Society of Heart and Lung Transplantation will honor Jon Kobashigawa, MD, as the recipient of the ISHLT’s 2023 Lifetime Achievement Award.

Este webinar tiene como objetivo mostrar tanto el manejo médico, así como las indicaciones de terapias avanzadas en el paciente con insuficiencia cardiaca estadio D. Se presentará bajo la perspectiva del ISHLT en colaboración con la Sociedad Mexicana de Cardiología.

ISHLT is pleased to welcome Olivia Taylor as full-time Education Programs Administrator, as of 17 January. Olivia will be responsible for comprehensive support in the development, implementation, and evaluation of events that are part of ISHLT’s education portfolio, including both in-person and online content.

A new joint guideline published today by the HFSA and ISHLT addresses the growing availability and use of acute or temporary mechanical support devices. The joint guideline provides critical recommendations and protocols for the management of patients requiring acute mechanical circulatory support (MCS), with the goals of improving quality of life and reducing the high mortality rates and complications associated with cardiogenic and pulmonary shock.

The new ISHLT/HFSA Joint Guideline on Acute Mechanical Circulatory Support is now available digitally in The Journal of Heart and Lung Transplantation. A collaborative effort commissioned by ISHLT and HFSA has developed this critically-needed guideline for the management of patients requiring acute mechanical circulatory support (MCS).

The Final Program for the 43rd International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions is now available. Attendees will meet in-person in Denver, CO USA on 19-22 April, 2023. The program features presentations spanning a breadth of clinical practice and research concerning heart and lung transplantation, advanced heart and lung disease, mechanical circulatory support, and pulmonary vascular disease.

As the ISHLT community looks forward to the ISHLT2023 Annual Meeting & Scientific Sessions, ISHLT announces the Chairs for the 2024 and 2025 Annual Meetings of the Society.

JHLT: The Podcast kicks off 2023 with a look back at 2022. Daniel R. Goldstein, MD, Editor-in-Chief of JHLT, joins the JHLT Digital Media Editors for a recap of the past year of The Journal of Heart and Lung Transplantation.

ISHLT has announced the results of the 2022 member election for the 2023 Board of Directors as well as leadership positions in the Professional Communities. The Society will welcome six members to the Board of Directors and 14 leaders across various specialties to serve as representatives to the 4 ISHLT Interdisciplinary Network Steering Committees and the Early Career & Trainee Committee beginning 1 May, 2023, immediately following the ISHLT 43rd Annual Meeting & Scientific Sessions.

ISHLT and the European Society for Organ Transplantation (ESOT) have collaborated to offer an Academy course on Mechanical Circulatory Support on 13 November, concurrently with the first day of the ESOT TLJ 3.0 Consensus Conference.

ISHLT has opened abstract submissions for its 43rd Annual Meeting & Scientific Sessions in Denver, Colorado on 19-22 April, 2023. This event will feature educational content spanning the breadth of clinical practice and research concerning heart and lung transplantation, advanced heart and lung disease, mechanical circulatory support, and pulmonary vascular disease.

Abstracts presented at the International Society for Heart and Lung Transplantation Annual Meeting gathers the latest research from around the world on caring for and improving outcomes for patients with advanced heart and lung disease.

Recognizing that abortion is a controversial issue approached in many ways around the world, the June 24, 2022, United States Supreme Court decision overturning Roe vs. Wade provides an important opportunity to remind those making health policy decisions of the added complexities end-stage heart and lung diseases bring to the reproductive decisions facing women of child-bearing potential, particularly those who have received a heart and/or lung transplant.

The International Society for Heart and Lung Transplantation (ISHLT) named Rebecca Cogswell, MD, the Medical Director of the Society’s International Thoracic Organ Transplant (TTX) Registry. Dr. Cogswell succeeds Josef Stehlik, MD, MPH, who concludes eleven years of service as Registry Medical Director, during which he expanded the registry’s international participation, use and citations, and recently completed a process to ensure data collection is robust and GDPR compliant.

For the eighth year in a row, The Journal of Heart and Lung Transplantation’s Impact Factor earned the publication the number one ranking in the transplantation category. JHLT has also maintained its ranking of 4th in Surgery and 5th in Respiratory, and increased its rank to 10th in the highly competitive Cardiac & Cardiovascular Systems category (from 13 in 2020).

The International Society for Heart and Lung Transplantation (ISHLT) awarded grants to three researchers its 2022 Annual Meeting. ISHLT grants fund research to improve the care of patients with advanced heart and lung disease through transplantation, mechanical circulatory support (MCS), and innovative therapies.

The International Society for Heart and Lung Transplantation (ISHLT) will follow the xenotransplantation presentation from its Annual Meeting opening plenary session with an in-depth xenotransplantation webinar, 25 May at noon EDT on ISHLTv, the online education platform for the international heart and lung transplantation community.

During its 42nd Annual Meeting in Boston, the International Society of Heart and Lung Transplantation honored the recipient of the 2022 Lifetime Achievement Award, Hannah Valantine, MD, FRCP, MBBS.

ISHLT has established a new sister organization: the ISHLT Foundation. This new entity serves as the charitable arm of ISHLT, and will fund a global portfolio of research grants and fellowship awards to improve patient care for advanced heart and lung disease.